Loomis, Sayles & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696K Sell
2,741
-242
-8% -$56.4K ﹤0.01% 512
2026
Q1
$729K Sell
2,983
-15,791
-84% -$3.68M ﹤0.01% 511
2025
Q4
$3.89M Sell
18,774
-18,378
-49% -$3.63M ﹤0.01% 427
2025
Q3
$6.89M Sell
37,152
-39,131
-51% -$6.7M 0.01% 409
2025
Q2
$11.7M Buy
76,283
+27,862
+58% +$4.28M 0.01% 348
2025
Q1
$8.03M Sell
48,421
-33,172
-41% -$5.19M 0.01% 380
2024
Q4
$11.8M Sell
81,593
-6,018
-7% -$933K 0.01% 348
2024
Q3
$14.2M Buy
87,611
+26,869
+44% +$4.28M 0.02% 307
2024
Q2
$8.88M Buy
60,742
+4,958
+9% +$737K 0.01% 378
2024
Q1
$8.82M Buy
55,784
+17,513
+46% +$2.79M 0.01% 368
2023
Q4
$6M Buy
38,271
+11,040
+41% +$1.69M 0.01% 386
2023
Q3
$4.24M Sell
27,231
-2,337
-8% -$386K 0.01% 400
2023
Q2
$4.89M Sell
29,568
-15,396
-34% -$2.48M 0.01% 399
2023
Q1
$6.97M Sell
44,964
-269
-0.6% -$43.4K 0.01% 368
2022
Q4
$7.99M Sell
45,233
-961
-2% -$166K 0.02% 334
2022
Q3
$7.55M Sell
46,194
-133,890
-74% -$22.7M 0.02% 336
2022
Q2
$32M Sell
180,084
-114,321
-39% -$20.4M 0.06% 157
2022
Q1
$52.2M Buy
294,405
+36,059
+14% +$6.14M 0.07% 121
2021
Q4
$44.2M Sell
258,346
-44,513
-15% -$7.29M 0.05% 173
2021
Q3
$48.9M Buy
302,859
+15,640
+5% +$2.67M 0.06% 150
2021
Q2
$47.3M Sell
287,219
-24,653
-8% -$4.08M 0.06% 161
2021
Q1
$51.3M Buy
311,872
+205,405
+193% +$33.2M 0.07% 135
2020
Q4
$16.8M Buy
106,467
+91,560
+614% +$13.5M 0.02% 280
2020
Q3
$2.22M Sell
14,907
-209
-1% -$30.9K ﹤0.01% 412
2020
Q2
$2.13M Sell
15,116
-916
-6% -$133K ﹤0.01% 415
2020
Q1
$2.1M Sell
16,032
-3,705
-19% -$526K ﹤0.01% 424
2019
Q4
$2.88M Sell
19,737
-13,033
-40% -$1.77M ﹤0.01% 421
2019
Q3
$4.24M Sell
32,770
-267
-0.8% -$35.2K 0.01% 413
2019
Q2
$4.6M Sell
33,037
-3,471
-10% -$480K 0.01% 419
2019
Q1
$5.1M Buy
36,508
+7,864
+27% +$1.05M 0.01% 427
2018
Q4
$3.7M Sell
28,644
-15,668
-35% -$2.19M 0.01% 442
2018
Q3
$6.12M Sell
44,312
-39,595
-47% -$5.26M 0.01% 455
2018
Q2
$10.2M Sell
83,907
-64,756
-44% -$8.08M 0.02% 421
2018
Q1
$19.1M Buy
+148,663
New +$20.1M 0.04% 263
2017
Q3
Sell
-26,213
Closed -$3.47M 950
2017
Q2
$3.47M Sell
26,213
-34,817
-57% -$4.44M 0.01% 529
2017
Q1
$7.6M Sell
61,030
-49,793
-45% -$5.95M 0.02% 459
2016
Q4
$12.8M Buy
110,823
+88,510
+397% +$10.2M 0.03% 380
2016
Q3
$2.64M Buy
22,313
+388
+2% +$47.1K 0.01% 560
2016
Q2
$2.66M Sell
21,925
-1,774
-7% -$202K 0.01% 552
2016
Q1
$2.56M Buy
23,699
+14,659
+162% +$1.52M 0.01% 519
2015
Q4
$929K Buy
9,040
+3,590
+66% +$361K ﹤0.01% 586
2015
Q3
$509K Buy
5,450
+5,191
+2,004% +$502K ﹤0.01% 622
2015
Q2
$25K Buy
+259
New +$25.9K ﹤0.01% 747
2015
Q1
Sell
-66,031
Closed -$6.91M 750
2014
Q4
$6.91M Buy
66,031
+79
+0.1% +$8.32K 0.02% 523
2014
Q3
$7.03M Sell
65,952
-366,275
-85% -$38M 0.02% 520
2014
Q2
$45.2M Buy
432,227
+366,275
+555% +$37M 0.13% 162
2014
Q1
$6.48M Sell
65,952
-384,033
-85% -$35.6M 0.02% 531
2013
Q4
$41.2M Sell
449,985
-20,805
-4% -$1.92M 0.12% 176
2013
Q3
$40.8M Buy
470,790
+466,490
+10,849% +$41.8M 0.13% 170
2013
Q2
$369 Buy
+4,300
New +$365K ﹤0.01% 634

Other funds holding JNJ

Loomis, Sayles & Company's JNJ Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Johnson & Johnson (JNJ) stake by 8.1% in Q2 2026, selling an estimated $56.4K and leaving 2,741 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Loomis, Sayles & Company first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $52.2M in Q1 2022. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Loomis, Sayles & Company held 2,741 shares of Johnson & Johnson worth $696K as of Q2 2026.
  • Loomis, Sayles & Company sold 242 Johnson & Johnson shares in Q2 2026, an estimated $56.4K.
  • Johnson & Johnson made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #512 holding.
  • Loomis, Sayles & Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Loomis, Sayles & Company's Johnson & Johnson position peaked at $52.2M in Q1 2022.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.